User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Oct 14 2017 17:58 IST RSS 2.0
 
1 to 20 of 2,813    
Base Erosion and Profit Shifting guidelines stump MNCs 14.10.2017 ET: Pharma
Under BEPS, multinationals will be required to declare details of revenues earned, taxes paid, employees hired, supply chain management in every country they operate in.
Also found in: [+]
Activists challenge Pneumonia vaccine patent in Delhi High Court 14.10.2017 DNA: Mumbai
Activists have challenged the patent claims of pharma giant Pfizer on a vaccine for pneumonia in the Delhi High Court. Médecins Sans Frontières or Doctors Without Borders (India) has filed a petition to overturn the patent granted earlier this year, on August 13 by the Indian Patent Office to Pfizer. “India has dashed hopes for improved access to an affordable PCV13 when it granted a patent to Pfizer for its PCV 13 product, marketed as Prevnar13, which will expire only in 2026,” a statement issued by MSF said. In the petition, MSF argues that in August 2017, the Delhi Patent Office erroneously granted a patent to Pfizer by disregarding the evidence MSF produced indicating that the pharmaceutical giant’s claim to a patent was spurious. MSF argued that the mere addition of serotypes to the already established 7-valent vaccine did not involve a technical advancement – it was merely a tactic to preserve Pfizer’s monopoly for many more years. The decision also has broader implications, as it indicates a ...
Also found in: [+]
MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patent 14.10.2017 ET: Pharma
The Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the brand ‘Prevenar13’ for over 10 years.
Also found in: [+]
U.S. STOCKS ON THE MOVE-Oracle, Genworth, Airlines, Carnival Corp, Mirati Therapeutics 15.9.2017 TOI: Intl Business
MARKETS-USA-STOCKS/PULSE:BUZZ-U.S. STOCKS ON THE MOVE-Oracle, Genworth, Airlines, Carnival Corp, Mirati Therapeutics
Also found in: [+]
Challenge of Allergan tribal patent deal in uncharted legal territory 15.9.2017 TOI: Intl Business
ALLERGAN-PATENTS/ (CORRECTED):REFILE-Challenge of Allergan tribal patent deal in uncharted legal territory
Also found in: [+]
Pharma companies inflating R&D costs? 14.9.2017 TOI: India
Also found in: [+]
Mylan says Allergan misusing tribal sovereignty in patent dispute 13.9.2017 TOI: Intl Business
ALLERGAN-PATENTS/MYLAN:Mylan says Allergan misusing tribal sovereignty in patent dispute
Also found in: [+]
U.S. tribal patent deal could have big impact on generic drug market 12.9.2017 TOI: Intl Business
ALLERGAN-PATENTS/MOHAWK:U.S. tribal patent deal could have big impact on generic drug market
Also found in: [+]
Modi govt developed Brand India: Amit Shah 10.9.2017 DNA: Mumbai
In his first address to India Inc at the Federation of Indian Chambers of Commerce and Industry's national executive meet, BJP chief Amit Shah on Saturday described various measures taken by Modi government, like GST and demonetization, as an effort to implement policies aimed at long-term gains. "We are looking to provide a stable policy for 30 years," said Shah adding that GST will reap benefits in the next 10 years. He said the biggest achievement of Modi government has been bringing forth a paradigm shift in the scale of thinking. "An image of Brand India has developed because of PM Modi's government." He asked organisations like FICCI to constitute consortium for research and development, especially in sectors like pharmaceuticals, so the country can make a profit from patent registration and intellectual property rights. Shah lambasted the UPA government for its 10-year rule riddled with scams and blamed it on the accumulated NPAs (non-performing assets). "The country was engulfed in an atmosphere ...
Also found in: [+]
London-listed drugmaker Indivior shares crash after U.S. patent blow 1.9.2017 TOI: Intl Business
INDIVIOR-RULING:London-listed drugmaker Indivior shares crash after U.S. patent blow
Also found in: [+]
UPDATE 1-London-listed drugs firm Indivior suffers setback in U.S. patents ruling 1.9.2017 TOI: Intl Business
INDIVIOR-RULING/ (CORRECTED, UPDATE 1):REFILE-UPDATE 1-London-listed drugs firm Indivior suffers setback in U.S. patents ruling
Also found in: [+]
Otsuka licenses Mylan subsidiary to bring MDR TB drug delamanid to India 25.8.2017 ET: Pharma
MDR TB is on the rise in India which, together with China and Russia, accounts for over half of these cases worldwide, according to a recent study.
Also found in: [+]
Samsung, Biogen version of AbbVie's Humira approved in Europe 25.8.2017 TOI: Intl Business
BIOGEN-HUMIRA/:Samsung, Biogen version of AbbVie's Humira approved in Europe
Also found in: [+]
Otsuka enters deal with Mylan to bring MDR TB drug to India 24.8.2017 ET: Pharma
The Drug Controller General of India has granted Mylan’s subsidiary approval for the drug, according to a release by the company. The drug, delamanid, was discovered and developed by Otsuka.
Also found in: [+]
Novartis receives EU approval for breast cancer drug Kisqali 24.8.2017 TOI: Intl Business
NOVARTIS-KISQALI/ (UPDATE 1):UPDATE 1-Novartis receives EU approval for breast cancer drug Kisqali
Also found in: [+]
India grants Pfizer patent for pneumonia vaccine; health groups say disease treatment will be out of reach for poor 22.8.2017 DNA: Wide Angle
India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations. The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026. It's a big victory for the U.S. drugmaker in a market that has the world's largest number of pneumonia cases, a lung disease that kills nearly a million children a year globally. The decision also has international implications, as several poorer nations rely on India's robust drugs industry to supply cheaper copies of medicines and vaccines. It also comes at a time of ongoing U.S. pressure on India to tighten its patent laws. The United States Trade Representative expressed concerns about India's intellectual property laws in a report in June, and listed it among countries whose IP laws unfairly favour local companies. Pfizer's vaccine protects ...
Also found in: [+]
Indian patent office grants patent to Pfizer on pneumonia vaccine 22.8.2017 TOI: India
Also found in: [+]
India grants Pfizer patent on pneumonia vaccine in blow to aid group 22.8.2017 TOI: Intl Business
PFIZER-INDIA/VACCINE (UPDATE 1):UPDATE 1-India grants Pfizer patent on pneumonia vaccine in blow to aid group
Also found in: [+]
India grants Pfizer patent for blockbuster brand Prevenar 13 22.8.2017 ET: Pharma
India has seven pneumonia related deaths per 1,000 live births, according to the 2016 Pneumonia and Diarrhea Progress Report.
Also found in: [+]
Pfizer revenue misses on lower Prevnar, Enbrel sales 1.8.2017 TOI: Intl Business
PFIZER-RESULTS/ (UPDATE 2):UPDATE 2-Pfizer revenue misses on lower Prevnar, Enbrel sales
Also found in: [+]
1 to 20 of 2,813